March 13, 2020
An Illinois federal judge granted final approval on Friday to a settlement that would provide Akorn Inc.'s investors with $30 million in cash and resolve claims that the drugmaker's misconduct sunk a multibillion-dollar merger.
August 26, 2019
An Illinois federal judge granted preliminary approval on Monday to a settlement that would provide Akorn Inc.'s investors $30 million in cash and resolve claims that the drugmaker's misconduct sunk a multibillion-dollar merger.
August 12, 2019
Pharmaceutical manufacturer Akorn Inc. and its investors settled a suit that would provide $30 million in cash and distribute more than 8 million shares of Akorn stock to class members, according to a motion for preliminary approval filed Friday in Illinois federal court.
July 08, 2019
Akorn Inc. investors have asked an Illinois federal judge for class certification in their securities fraud suit claiming the generic-drug maker and its executives falsified regulatory submissions that sunk a multibillion-dollar merger and tanked Akorn's share price.